Advertisement

Person › Details
Vasant (Vas) Narasimhan (Novartis Pharmaceuticals Corporation)
Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines
![]() |
Product | pharmaceutical |
Product 2 | vaccine | |
Record changed: 2024-12-03 |
Advertisement

More documents for Vasant (Vas) Narasimhan
- [1] PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ....
- [2] Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel....
- [3] Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel....
- [4] Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel....
- [5] Molecular Partners AG. (1/10/22). "Press Release: Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19". Zürich-Schlieren & Concord, MA....
- [6] Molecular Partners AG. (10/28/20). "Press Release: Molecular Partners Announces Collaboration with Novartis to Develop Two DARPin Therapies Designed for Potential Use against COVID-19". Zürich-Schlieren....
- [7] Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel....
- [8] Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel....
- [9] Novartis AG. (10/1/19). "Press Release: Novartis and Microsoft Announce Collaboration to Transform Medicine with Artificial Intelligence". Basel & Redmond, WA....
- [10] Novartis AG. (5/24/19). "Press Release: AveXis Receives FDA Approval for Zolgensma, the First and Only Gene Therapy for Pediatric Patients with Spinal Muscular Atrophy (SMA)". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top